Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial.
Bogaerts J, Cardoso F, Buyse M, Braga S, Loi S, Harrison JA, Bines J, Mook S, Decker N, Ravdin P, Therasse P, Rutgers E, van 't Veer LJ, Piccart M; TRANSBIG consortium.
Bogaerts J, et al. Among authors: mook s.
Nat Clin Pract Oncol. 2006 Oct;3(10):540-51. doi: 10.1038/ncponc0591.
Nat Clin Pract Oncol. 2006.
PMID: 17019432
Review.